Corticosteroids in Severe Community-Acquired Pneumonia
Author Information
Author(s): Salluh Jorge IF, Póvoa Pedro, Soares Márcio, Castro-Faria-Neto Hugo C, Bozza Fernando A, Bozza Patrícia T
Primary Institution: Instituto Nacional de Câncer, Rio de Janeiro, Brazil
Hypothesis
What is the impact of corticosteroids on the outcomes of patients with severe community-acquired pneumonia?
Conclusion
Corticosteroids should not be recommended as a standard treatment for severe community-acquired pneumonia, but their use may be safe in patients needing them.
Supporting Evidence
- Two studies found a significant reduction in mortality for patients with severe CAP treated with corticosteroids.
- Confalonieri et al. showed a 30% versus 0% mortality rate with hydrocortisone treatment.
- Garcia-Vidal et al. found corticosteroids strongly associated with lower mortality in a large cohort study.
Takeaway
This study looked at whether giving steroids helps people with a bad lung infection. It found that while steroids might not be the best standard treatment, they can be safe for some patients.
Methodology
A systematic review of studies evaluating corticosteroids in severe community-acquired pneumonia was conducted using MEDLINE, Cochrane database, and CINAHL.
Potential Biases
Selection bias may have influenced the results due to differing inclusion criteria across studies.
Limitations
The studies reviewed had small sample sizes and varied treatment regimens.
Participant Demographics
The studies included adult patients with severe community-acquired pneumonia, with some studies focusing on specific severity classes.
Statistical Information
P-Value
0.009
Confidence Interval
0.113 to 0.732
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website